肿瘤药学
腫瘤藥學
종류약학
ANTI-TUMOR PHARMACY
2015年
2期
134-137
,共4页
谢宁%陈伟业%吴玲%邓敏端%吴爱明
謝寧%陳偉業%吳玲%鄧敏耑%吳愛明
사저%진위업%오령%산민단%오애명
氯胺酮%子宫颈癌%细胞因子%术后疼痛
氯胺酮%子宮頸癌%細胞因子%術後疼痛
록알동%자궁경암%세포인자%술후동통
Ketamine%Cervical cancer%Cytokine%Postoperative pain
目的:探讨小剂量氯胺酮对子宫颈癌患者围术期炎性细胞因子及术后疼痛的影响。方法65例子宫颈癌择期手术患者随机分为氯胺酮组(n=31)和对照组(n=34)。麻醉诱导后,氯胺酮组术前给予氯胺酮0.3 mg·kg-1静注,随后持续静注氯胺酮4μg·kg-1·min-1直至术毕;对照组给予相同容量的生理盐水静注。两组分别于麻醉诱导前、术后2 h 及术后24 h 抽取外周静脉血检测血清肿瘤坏死因子-α(Tumor necrosis factor–alpha,TNF-α)、白细胞介素-6(interleukin-6,IL-6)及白细胞介素-8(interleukin-8,IL-8)的浓度。采用视觉模拟评分(visual analogue scale,VAS)评估两组术后2 h、24 h 和48 h 的疼痛评分。结果两组血清 TNF-α、IL-6和 IL-8水平均在术后升高(P<0.05),氯胺酮组术后2 h、24 h 的 TNF-α、IL-6、IL-8水平较对照组偏低(P<0.05)。氯胺酮组术后2 h 及术后24 h 的 VAS 评分显著低于对照组(P<0.05)。结论小剂量氯胺酮有助于减轻子宫颈癌患者术后疼痛程度,抑制炎性细胞因子的升高。
目的:探討小劑量氯胺酮對子宮頸癌患者圍術期炎性細胞因子及術後疼痛的影響。方法65例子宮頸癌擇期手術患者隨機分為氯胺酮組(n=31)和對照組(n=34)。痳醉誘導後,氯胺酮組術前給予氯胺酮0.3 mg·kg-1靜註,隨後持續靜註氯胺酮4μg·kg-1·min-1直至術畢;對照組給予相同容量的生理鹽水靜註。兩組分彆于痳醉誘導前、術後2 h 及術後24 h 抽取外週靜脈血檢測血清腫瘤壞死因子-α(Tumor necrosis factor–alpha,TNF-α)、白細胞介素-6(interleukin-6,IL-6)及白細胞介素-8(interleukin-8,IL-8)的濃度。採用視覺模擬評分(visual analogue scale,VAS)評估兩組術後2 h、24 h 和48 h 的疼痛評分。結果兩組血清 TNF-α、IL-6和 IL-8水平均在術後升高(P<0.05),氯胺酮組術後2 h、24 h 的 TNF-α、IL-6、IL-8水平較對照組偏低(P<0.05)。氯胺酮組術後2 h 及術後24 h 的 VAS 評分顯著低于對照組(P<0.05)。結論小劑量氯胺酮有助于減輕子宮頸癌患者術後疼痛程度,抑製炎性細胞因子的升高。
목적:탐토소제량록알동대자궁경암환자위술기염성세포인자급술후동통적영향。방법65례자궁경암택기수술환자수궤분위록알동조(n=31)화대조조(n=34)。마취유도후,록알동조술전급여록알동0.3 mg·kg-1정주,수후지속정주록알동4μg·kg-1·min-1직지술필;대조조급여상동용량적생리염수정주。량조분별우마취유도전、술후2 h 급술후24 h 추취외주정맥혈검측혈청종류배사인자-α(Tumor necrosis factor–alpha,TNF-α)、백세포개소-6(interleukin-6,IL-6)급백세포개소-8(interleukin-8,IL-8)적농도。채용시각모의평분(visual analogue scale,VAS)평고량조술후2 h、24 h 화48 h 적동통평분。결과량조혈청 TNF-α、IL-6화 IL-8수평균재술후승고(P<0.05),록알동조술후2 h、24 h 적 TNF-α、IL-6、IL-8수평교대조조편저(P<0.05)。록알동조술후2 h 급술후24 h 적 VAS 평분현저저우대조조(P<0.05)。결론소제량록알동유조우감경자궁경암환자술후동통정도,억제염성세포인자적승고。
Objective To investigate the effects of low-dose ketamine on perioperative cytokine response and postop-erative pain in cervical cancer patients. Methods A total of 65 patients who underwent cervical cancer surgical procedures were randomized into ketamine group (n=31) and control group (n=34). After induction of general anesthesia, patients in ketamine group received preoperative intravenous ketamine 0.3 mg·kg-1 and then continued intravenous ketamine 4 μg·kg-·min-1 until surgery completed. Patients in control group were given the same volume of saline injection. The levels of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8) from peripheral venous blood were assessed at the time points of before anesthesia induction, 2 hours and 24 hours after operation. Postoperative pain was evaluated us-ing visual analogue scale (VAS) at 2 hours, 24 hours and 48 hours respectively after surgery. Results The levels of TNF-α, IL-6 and IL-8 in both groups increased postoperatively (P<0.05), and the levels of TNF-α, IL-6 and IL-8 in ketamine group were lower than those in the control group at 2 hours and 24 hours after surgery (P<0.05). VAS scores in ketamine group were significantly lower than in control group at 2 hours and 24 hours after surgery (P<0.05). Conclusion Low-dose ketamine can relieve the severity of postoperative pain and regulate the serum levels of cytokine in cervical cancer patients.